Tokinolide ACAS# 112899-62-4 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products

| Cas No. | 112899-62-4 | SDF | Download SDF |
| PubChem ID | 163073899 | Appearance | Powder |
| Formula | C24H28O4 | M.Wt | 380.5 |
| Type of Compound | Miscellaneous | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | 6,16-di(butylidene)-5,17-dioxapentacyclo[9.4.3.01,11.02,10.03,7]octadeca-3(7),12-diene-4,18-dione | ||
| SMILES | CCCC=C1C2=C(C3C(CC2)C45C3(CCC=C4)C(=CCCC)OC5=O)C(=O)O1 | ||
| Standard InChIKey | UHSPLLCHEOVMGH-UHFFFAOYSA-N | ||
| Standard InChI | InChI=1S/C24H28O4/c1-3-5-9-17-15-11-12-16-20(19(15)21(25)27-17)24-14-8-7-13-23(16,24)22(26)28-18(24)10-6-4-2/h7,9-10,13,16,20H,3-6,8,11-12,14H2,1-2H3 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Tokinolide A Dilution Calculator
Tokinolide A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.6281 mL | 13.1406 mL | 26.2812 mL | 52.5624 mL | 65.703 mL |
| 5 mM | 0.5256 mL | 2.6281 mL | 5.2562 mL | 10.5125 mL | 13.1406 mL |
| 10 mM | 0.2628 mL | 1.3141 mL | 2.6281 mL | 5.2562 mL | 6.5703 mL |
| 50 mM | 0.0526 mL | 0.2628 mL | 0.5256 mL | 1.0512 mL | 1.3141 mL |
| 100 mM | 0.0263 mL | 0.1314 mL | 0.2628 mL | 0.5256 mL | 0.657 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2,3-Dihydroxy-2,3-dihydrosqualene (NSC837085)
Catalog No.:BCX2229
CAS No.:915385-29-4
- erythro-1-C-Syringylglycerol 4-O-beta-D-glucopyranoside
Catalog No.:BCX2228
CAS No.:942304-07-6
- Byakangelicin-3''-ethyl ether
Catalog No.:BCX2227
CAS No.:68047-30-3
- Leptodactylone
Catalog No.:BCX2226
CAS No.:61899-44-3
- Hopantenic acid (Dexpanthenol Impurity 4)
Catalog No.:BCX2225
CAS No.:49831-65-4
- (S)-7-O-Methylpeucedanol 3'-O-beta-D-glucopyranoside
Catalog No.:BCX2224
CAS No.:214627-06-2
- 9S,12S,13S-Trihydroxy-10E-octadecenoate
Catalog No.:BCX2223
CAS No.:97134-11-7
- 14-Acetoxy-12-senecioyloxytetradeca-2E,8E,10E-trien-4,6-diyn-1-ol
Catalog No.:BCX2222
CAS No.:113269-37-7
- 15R-Kirenol (ent-2alpha,15R,16,19-tetrahydroxypimar-8(14)-ene)
Catalog No.:BCX2221
CAS No.:1622876-96-3
- Higenamine 4'-O-beta-D-glucoside
Catalog No.:BCX2220
CAS No.:1440545-91-4
- Puerarin 6''-O-glucoside
Catalog No.:BCX2219
CAS No.:168060-90-0
- Isoswertisin
Catalog No.:BCX2218
CAS No.:6980-40-1
- Butanoic acid
Catalog No.:BCX2231
CAS No.:1977-33-9
- 2,3,5-Trihydroxy-2,3-dihydrosqualene
Catalog No.:BCX2232
CAS No.:1076200-13-9
- Deacetylcentapicrin
Catalog No.:BCX2233
CAS No.:60197-56-0
- Cronupapin methyl ester
Catalog No.:BCX2234
CAS No.:1454585-35-3
- Grammatophylloside B
Catalog No.:BCX2235
CAS No.:1425047-07-9
- Grammatophylloside A
Catalog No.:BCX2236
CAS No.:1425047-04-6
- Pubetallin
Catalog No.:BCX2237
CAS No.:75207-37-3
- Pubeside D
Catalog No.:BCX2238
CAS No.:335150-90-8
- Phyllangin
Catalog No.:BCX2239
CAS No.:854044-76-1
- threo-1-C-Syringylglycerol 4-O-beta-D-glucopyranoside
Catalog No.:BCX2240
CAS No.:942304-08-7
- Neoligustilide
Catalog No.:BCX2241
CAS No.:179382-45-7
- rel-(7S,8S,7''R,8''R)-3,3'',4'',5''-hexamethoxy-7-O-7'',8,8''-lignan
Catalog No.:BCX2242
CAS No.:50394-05-3
Intricate polycyclic dimeric phthalides derived from Angelica sinensis with potential to attenuate renal fibrosis.[Pubmed:41447944]
Bioorg Chem. 2026 Feb;169:109424.
Chronic kidney disease (CKD), characterized by fibrosis, is primarily treated clinically by regulating excessive renin-angiotensin-aldosterone system (RAAS). Our previous research showed that dimeric phthalides from Angelica sinensis had the potential to alleviate CKD by suppressing renin expression and RAAS activation. To advance the search for anti-fibrotic and nephroprotective natural phthalides, a systematic investigation of phthalide polymers of A. sinensis was conducted. In this work, twenty-five dimeric phthalides, including seven new dimers, angesinenolides G-M (1, 13, 17, 18, 22-24), and eighteen known congeners were isolated from A. sinensis. The structures of new compounds were elucidated by spectroscopic and crystallographic data analyses. The anti-fibrosis activities of these phthalides were evaluated in TGF-beta1-stimulated HK-2 cells. The results revealed that phthalide dimers 5 (Tokinolide A, TA) and 13 significantly reduced the level of renin gene and down-regulated the fibrosis-related protein markers such as fibronectin (Fn), collagen I (Col I), E-cadherin and alpha-SMA. Mechanistically, treatment with phthalide dimers reduced the levels of renin and Ang II in the RAAS pathway and inhibited the activation of TGF-beta1/Smad signaling pathway in TGF-beta1-stimulated cells. In the 5/6 nephrectomy (Nx) model, the anti-renal fibrotic efficacy of TA was further substantiated, with in vivo mechanisms consistent with the cellular findings. Overall, these findings expanded the natural phthalide dimers of A. sinensis and supported TA as an attractive lead compound for renal fibrosis and renin-targeted CKD therapy.
Neuroprotective and Cytotoxic Phthalides from Angelicae Sinensis Radix.[Pubmed:27128890]
Molecules. 2016 Apr 26;21(5):549.
Seven phthalides, including a new dimeric one named tokinolide C (7), were isolated from Angelicae Sinensis Radix and characterized. The structures of these compounds were elucidated on the basis of comprehensive analysis of spectroscopic data and comparison with literature data. All of the compounds were evaluated for their cytotoxic activities against the A549, HCT-8, and HepG2 cancer cell lines. Riligustilide (4) showed cytotoxicity against three cancer cell lines, with IC50 values of 13.82, 6.79, and 7.92 muM, respectively. Tokinolide A (6) and tokinolide C (6) exerted low cytotoxicity in these cancer cell lines, while the remaining compounds were inactive. Flow cytometry analysis was employed to evaluate the possible mechanism of cytotoxic action of riligustilide (4). We observed that compound 4 was able to arrest the cell cycle in the G1, S phases and induce apoptosis in a time-dependent manner in HCT-8 cell lines. In addition, these compounds were evaluated for neuroprotective effect against SH-SY5Y cells injured by glutamate. The result showed that ligustilide (1), Z-butylidenephthalide (3) and Tokinolide A (6) exhibited significant neuroprotective effects.


